Clinical Genomics has appointed Betsy Hanna as its president and CEO. In addition, she will join the firm's board of directors. Hanna succeeds Lawrence LaPointe as CEO, who will transition to the new role of chief innovation officer and serve as an advisor to the board. Hanna previously served as Clinical Genomics' chief commercial officer. Before that, she served as president and COO at Origin. Prior to Origin, Hanna held leadership positions at Johnson & Johnson Diagnostics, where she served as VP, strategic marketing as well as VP Europe, Mideast and Africa.